1. Home
  2. NVG vs AAPG Comparison

NVG vs AAPG Comparison

Compare NVG & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen AMT-Free Municipal Credit Income Fund

NVG

Nuveen AMT-Free Municipal Credit Income Fund

HOLD

Current Price

$12.81

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$27.77

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVG
AAPG
Founded
1999
2009
Country
United States
China
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
NVG
AAPG
Price
$12.81
$27.77
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.50
AVG Volume (30 Days)
568.8K
3.8K
Earning Date
01-01-0001
03-26-2026
Dividend Yield
4.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$54,524,554.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$368.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$16.50
52 Week High
$12.21
$48.45

Technical Indicators

Market Signals
Indicator
NVG
AAPG
Relative Strength Index (RSI) 60.63 42.22
Support Level $12.55 $27.48
Resistance Level $12.93 $28.49
Average True Range (ATR) 0.08 0.49
MACD 0.02 0.21
Stochastic Oscillator 77.66 37.17

Price Performance

Historical Comparison
NVG
AAPG

About NVG Nuveen AMT-Free Municipal Credit Income Fund

Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: